Seong YS - Search Results

1

Optimizing epidermal growth factor receptor-tyrosine kinase inhibitor treatment in lung cancer: a systematic review and meta-analysis of the influence of gastric acid suppressants.

Kim BK, Seong YS, Kwak SH, Lee EH, Lee SH, Kim EY, Chang YS, Kim CY. Kim BK, et al. Among authors: seong ys. Transl Lung Cancer Res. 2024 Nov 30;13(11):2934-2946. doi: 10.21037/tlcr-24-537. Epub 2024 Nov 18. Transl Lung Cancer Res. 2024. PMID: 39670008 Free PMC article.

2

Adiponectin-to-leptin ratio and incident chronic kidney disease: Sex and body composition-dependent association.

Park HS, Park SH, Seong Y, Kim HJ, Choi HY, Rhee Y, Park HC, Jhee JH. Park HS, et al. J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1298-1308. doi: 10.1002/jcsm.13475. Epub 2024 Apr 17. J Cachexia Sarcopenia Muscle. 2024. PMID: 38632706 Free PMC article.

3

Cumulative Blood Pressure Load and Incident CKD.

Park HS, Park SH, Seong Y, Kim HJ, Choi HY, Park HC, Jhee JH. Park HS, et al. Am J Kidney Dis. 2024 Dec;84(6):675-685.e1. doi: 10.1053/j.ajkd.2024.05.015. Epub 2024 Jul 30. Am J Kidney Dis. 2024. PMID: 39084487

4

Oral high-carbohydrate solution as an alternative dietary modality in patients with acute pancreatitis.

Lee SY, Lee J, Cho JH, Lee DK, Seong Y, Jang SI. Lee SY, et al. Pancreatology. 2024 Nov;24(7):1003-1011. doi: 10.1016/j.pan.2024.09.019. Epub 2024 Sep 24. Pancreatology. 2024. PMID: 39353844

5

Beta-Transducin Repeats-Containing Proteins as an Anticancer Target.

Kim DJ, Yi YW, Seong YS. Kim DJ, et al. Among authors: seong ys. Cancers (Basel). 2023 Aug 24;15(17):4248. doi: 10.3390/cancers15174248. Cancers (Basel). 2023. PMID: 37686524 Free PMC article. Review.

6

OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer.

Xie X, Laster KV, Li J, Nie W, Yi YW, Liu K, Seong YS, Dong Z, Kim DJ. Xie X, et al. Among authors: seong ys. Cell Mol Life Sci. 2023 Aug 30;80(9):272. doi: 10.1007/s00018-023-04931-4. Cell Mol Life Sci. 2023. PMID: 37646890 Free PMC article.

7

Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells.

Yi YW, You KS, Han S, Ha IJ, Park JS, Lee SG, Seong YS. Yi YW, et al. Among authors: seong ys. Cancers (Basel). 2022 Oct 24;14(21):5215. doi: 10.3390/cancers14215215. Cancers (Basel). 2022. PMID: 36358633 Free PMC article.

8

Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?

Yi YW, You KS, Park JS, Lee SG, Seong YS. Yi YW, et al. Among authors: seong ys. Int J Mol Sci. 2021 Dec 21;23(1):48. doi: 10.3390/ijms23010048. Int J Mol Sci. 2021. PMID: 35008473 Free PMC article. Review.

9

Doxycycline potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer cells.

Yi YW, Park NY, Park JI, Seong YS, Hong YB. Yi YW, et al. Among authors: seong ys. Am J Cancer Res. 2021 Jul 15;11(7):3515-3536. eCollection 2021. Am J Cancer Res. 2021. PMID: 34354858 Free PMC article.

10

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

You KS, Yi YW, Cho J, Park JS, Seong YS. You KS, et al. Among authors: seong ys. Pharmaceuticals (Basel). 2021 Jun 18;14(6):589. doi: 10.3390/ph14060589. Pharmaceuticals (Basel). 2021. PMID: 34207383 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters